ABSTRACT
INTRODUCTION D
ETECTION METHODS OF INTRAGENIC MUTATIONS in diseasecausing genes are well established. However, the possibility of identifying large genomic deletions has been limited due to technical difficulties. At present, different techniques are used for the detection of genomic copy number changes: e.g., comparative genomic hybridization (Kallioniemi et al., 1992) , fluorescent in situ hybridization (FISH) (Klinger et al., 1992) , bacterial artificial chromosome (BAC) arrays (Snijders et al., 2001) , Southern blot (Southern, 1975) , and loss-ofheterozygosity assays (Devilee et al., 2001) . Cytogenetic analysis using FISH techniques is a valuable tool for characterizing and verifying structural abnormalities at the chromosomal level. Recent developments in probe labeling techniques and genome sequence information have improved the usefulness of the method for detecting abnormalities in limited chromosomal regions. However, the cytogenetic techniques, as well as the Southern blot-derived methods, are of limited use in the clinical laboratory due to their tedious and labor-intensive nature. With conventional exon-specific mutation-detection methods based on PCR amplification techniques, it is almost impossible to detect exon deletions and duplications, due to the amplification of the wild-type allele. Several multiplex PCR amplification techniques, e.g., quantitative multiplex PCR of short fluorescent fragments (Casilli et al., 2002) , have been developed for copy number analysis of genomic sequences. However, the presence of multiple PCR primers in a single reaction tube often reduces robustness of PCR and reliability of quantification.
The PCR-based quantitative multiplex ligation-dependent probe amplification (MLPA) (Schouten et al., 2002) method makes it possible simultaneously to determine the relative copy number of all exons in the APC gene, the major disease-causing gene of familial adenomatous polyposis (FAP; MIM #175100), using only one pair of PCR primers in a single reaction. Fragments are separated by automated capillary electrophoreses identifying each fragment based on the PCR fragment length. This method has recently been used to detect deletions with high sensitivity in BRCA1 (Hogervorst et al., 2003; Montagna et al., 2003) , hMLH1 and hMSH2 (Gille et al., 2002; Taylor et al., 2003) .
Quantitative real-time PCR (QRT-PCR) enables the accurate determination of initial concentrations of a DNA fragment by continous measurement during the course of the amplification. Copy number is assessed by comparing the measured concentrations relative to a reference gene in the same sample. We have developed a QRT-PCR method based on the LightCycler instrument and hybridization probes to detect deletions of APC exons 3 and 11. QRT-PCR have been used for detection of alterations of copy number in early-onset parkinsonism (Hedrich et al., 2001 ) using a similar approach and, using a real-time PCR exonuclease assay, to detect deletions of APC exon 14 (Sieber et al., 2002) .
Deletions of entire disease genes have been shown to constitute a nonnegligible part of mutations of these genes (Norman et al., 1990; Petrij-Bosch et al., 1997; Wijnen et al., 1998) . In some cases, they are correlated to a specific disease phenotype, e.g., malignant peripheral nerve sheath tumor in neurofibromatosis type 1 (De Raedt et al., 2003) . To perform presymptomatic screening in family members affected with hereditary diseases, new high-throughput methods had to be developed for the detection of large deletions.
FAP is an inherited autosomal dominant disease with the gene locus on chromosome 5q22 (Bodmer et al., 1987) . The main manifestation of this disease is characterized by the formation of adenomatous polyps in the small and large intestine and, due to the large number of polyps, is associated with an almost 100% risk of developing colorectal cancer (CRC). The introduction of presymptomatic screening programs and the possibility of performing colectomy or proctocolectomy in mutation carriers has reduced the morbidity and mortality in CRC dramatically. A genotype-phenotype correlation, i.e., the specific germ-line mutation of the APC gene predicting the clinical course of the disease, has been shown to exist for some features of FAP, such as the attenuated phenotype and congenital hypertrophy of the retinal pigment epithelium (Fearnhead et al., 2001) . The main cause of FAP-related death is the development of duodenal cancer and desmoid tumors in patients. It is important to recognize the genotypes associated with these manifestations for adequate treatment of FAP patients (Davies et al., 1995; Björk et al., 2001) .
Germ-line mutations in the APC gene causing FAP are mainly base substitutions or small insertions/deletions introducing premature truncations of the APC protein (Stenson et al., 2003) . However, standard techniques for mutation detection fails to identify the disease causing change in 20-50% of the affected cases (Heinimann et al., 2001) . Large deletions excluding the entire APC gene have been described only in a few cases of FAP (Barber et al., 1994; Mandl et al., 1996; De Rosa et al., 1999; Pilarski et al., 1999; Flintoff et al., 2001; Raedle et al., 2001) . To investigate whether large deletions of the APC gene are responsible for FAP in part of the families with unidentified APC mutation, two independent quantitative methods, MLPA and QRT-PCR, were developed. We here describe the identification of deletion mutations of the APC gene in patients with classical FAP; one whole APC gene deletion and one deletion of APC exon 11 through exon 13. The whole gene deletion was further verified on chromosome level by using FISH on metaphase spreads. The breakpoints of the exon 11-13 deletion were characterized by long-range PCR and sequencing.
MATERIALS AND METHODS

Patients
Twenty seven unrelated patients from the Swedish polyposis registry diagnosed with FAP, or attenuated FAP, in whom no germ-line APC mutation had been found using standard mutation detection techniques, e.g., protein truncation test (PTT), DNA sequencing, denaturing high-performance liquid chromatography (dHPLC), and single-strand conformational polymorphism (SSCP) were included. The study has been approved by the local ethics committees.
Patient A, a 55-year-old woman, was diagnosed with FAP at family screening in 1970. Both her father and an uncle had FAP. Colectomy with ileorectal anastomosis was performed in the same year. The colonic mucosa exhibited features of dense polyposis. Rectal excision was done in 1997 because of repeated findings of high-grade dysplasia. Regular upper endoscopies have been performed since 1989. Fundic gland polyps were present from the beginning. In 1991, celiac disease was diagnosed, which has been resolved completely on a glutenfree diet. Duodenal adenomas were not present until 2002. So far she has no signs of extraintestinal manifestations of the disease.
Patient B is member of a large typical FAP family from northern Sweden with verified polyposis of the colon in four generations. A fraction of the family pedigree is shown in Figure 4A . The patient was diagnosed at age 37. In the older generations, 4 persons died of CRC between the ages 35 and 50, whereas in the younger generations 2 persons have been diagnosed with polyposis at coloscopy surveillance at the ages of 18 and 25, respectively. In addition, two obligate female carriers have been diagnosed with thyroid cancer at 28 and 42 years of age (not shown in pedigree).
Patient C was diagnosed with FAP at 26 years of age and colectomy with ileorectal anastomosis was performed shortly thereafter. Fifty to 100 colorectal polyps were found. Patient C has six relatives in three generations with FAP.
DNA isolation
Genomic DNA was isolated from samples of venous blood, anticoagulated in EDTA. DNA preparation was performed using the PuregeneR DNA Isolation Kit (Gentra Systems, Minneapolis, MN) according to the manufacturer's recommendations.
APC exon copy number detected by MLPA
Mutation analysis was carried out using an APC-specific MLPA test. The probes included in the APC probe mix, P043, are listed in Table 1 . The P043 probe mix is now commercially available at MRC-Holland (http://www.mrc-holland.com, Amsterdam, NL). The MLPA was performed in a PTC-100 (Multi) thermal cycler with heated lid. In brief, approximately 100 ng of DNA was denatured at 98°C for 5 min. The APC probe mix was added, and, following a 1-min incubation at 95°C, the probes were allowed to hybridize overnight to the target DNA at 60°C. Ligation of the two oligonucleotides of each probe was carried out with the temperature-stable Ligase-65 enzyme (MRC-Holland) for 15 min at 54°C. After inactivation of the ligase, the mix was subjected to PCR amplification by adding a quarter of the ligation reaction mix to 40 l of PCR reaction mix containing PCR buffer, dNTPs, SALSA polymerase (MRC-Holland), and PCR primers (one unlabeled and one carboxyfluorescein-labeled) at 60°C.
The PCR profile used was 33 cycles of denaturation at 95°C for 20 sec, annealing at 60°C for 30 sec, and extension at 72°C for 60 sec, followed by a final extension for 20 min. The amplified fragments were analyzed on an ABI 3100 Genetic Analyzer (Applied Biosystems, Foster City, CA) using Genescan-ROX 500 size standards (Applied Biosystems).
Fragment analysis was performed using Genescan software. Data analyses of sample DNA were done by exporting the size and peak areas to an Excel file. Nonspecific amplification products, primer dimers, and the peaks obtained from the MLPA control mix were identified by their low peak area or short lengths and removed. When only the peak areas of the expected MLPA products were left, all peak areas were normalized by dividing the peak area by the combined peak area of all control peaks of the sample. Compared to a control reaction, the relative peak area of each amplification product reflects the relative copy number of the target sequence of that probe in the analyzed sample. Samples showing a change of gene dosage were analyzed at least twice and compared to separate controls.
FISH analysis
Confirmation of the MLPA and QRT-PCR results was performed by FISH analysis (Pinkel et al., 1986; Johannesson et al., 1991) Shaded rows indicate APC-specific probes. a Names of the probes included in the APC probe mix P043 (MRC-Holland). b Expected ratio for two copies of an exon is 1.00.
covering APC exon 1 through exon 14 and the 5Ј part of exon 15 were generated from cDNA fragments corresponding to APC exon 1-11, exon 9-15, and exon 7-15, obtained from RT-PCR reactions on lymphocyte RNA as previously described (Björk et al., 2001) . A pool of these APC cDNA fragments were subjected to nick translation labeling with SpectrumOrange dUTP (Vysis, Downers Grove, IL) using the nick translation reagent kit (Vysis, Downers Grove, IL). A probe specific for the D5S23 locus within 5p15.2 labeled with SpectrumGreen was used as chromosome 5-specific probe (Vysis, Downers Grove, IL).
QRT-PCR
QRT-PCR was performed in the LightCycler instrument using the Fast Start DNA Master Hybridization Probes Kit (Roche Diagnostics, Mannheim, Germany). Two sets of primers and hybridization probes were designed (Table 2) , with the assistance of the LCProbe design or Vector NTI software, to cover APC exons 3 and 11. To avoid potential problems due to intronic variation, PCR primers were designed to be located within the same exon. Primers and probes for a 110-bp fragment of the human ␤-globin gene, which was used as an internal standard, were supplied in the LightCycler-Control Kit DNA (Roche Diagnostics). Amplification/detection reactions were performed in a volume of 12 l containing 1.2 l of FastStartMastermix (containing reaction buffer, dNTP mix, and Taq DNA polymerase), 0.4-1 M of each APC-specific primer, 0.188 M of each APC-specific labeled hybridization probe, 3.1-4.1 mM MgCl 2 , 0.375 M of each ␤-globin primer, 0.15 M fluorescein-labeled ␤-globin probe, 0.3 M LC-Red 640-labeled ␤-globin probe, and 1-10 ng of genomic DNA. APC and ␤-globin-specific primers/probes were multiplexed for APC exon 3. For exon 11, the quantification of APC and ␤-globin was performed in separate reactions. Thermocycling was as follows: 95°C for 7 min, followed by 45 cycles of 95°C for 10 sec, 56°C for 10 sec, and 72°C for 15 sec. After the thermocycling, samples were subjected to melting curve analysis from 50 to 80°C. The measured fluorescence signal was corrected for background, and dual-color utilization when appropriate. Crossing points, i.e., the fractional cycle number where the rate of change in fluorescence is fastest, were determined by the Lightcycler software using the second derivative method. The initial concentration of each amplified fragment was calculated automatically by the software on the basis of the crossing points and a standard curve generated using human genomic DNA (Roche Diagnostics) of known concentration from 0.48-12 ng/reaction. All standards and samples were amplified in duplicate. If the inferred sample concentration was outside the standard curve range of concentrations or if the standard deviation was Ͼ10%, samples were reanalyzed. Gene copy number was determined by the ratio of the measured concentration of the APC gene and the corresponding concentration of the ␤-globin gene. A ratio between 0.82 and 1.22 was considered normal (Ͻ10 % error in measured concentration) and a ratio between 0.41 and 0.61 indicated that the analyzed APC exon was deleted in one allele. Samples for which an alteration of normal gene dosage was found were measured at least twice to verify the results.
Long-range PCR
PCR of long DNA fragments was performed with the Long Expand Template PCR system (Roche). Each reaction contained 1ϫ buffer, 0.35 mM dNTPs, 0.27 M of each primer, 1 l of enzyme mix, and approximately 100 ng of genomic DNA in a total volume of 30 l. The amplification reaction started with 2 min of denaturation at 92°C, followed by 10 cycles of 93°C for 15 sec, 60°C for 30 sec, 68°C for 8 min; 24 cycles of 93°C for 15 sec, 60°C for 30 sec, 68°C for 8 min ϩ 20 sec/cycle; and finally 7 min at 68°C. The primers used for amplification of exons 11-13 as a 13-kb wild-type fragment were 5Ј-ATCTGTCCTGCTGTGTGTGTTCTA-3Ј and 5Ј-CTCAGTG-CAATGTGCTGACA-3Ј. Breakpoints were verified by DNA sequence determination of purified PCR products.
RESULTS
APC exon copy number detected by MLPA and FISH analysis
One MLPA probe for each of the first 14 exons, three for exon 15, and three additional MLPA probes, two for the promoter region and one for the 5Ј untranslated region, were constructed to enable quantification of the APC gene (Table 1 ). For reference, 11 additional control probes were added to the probe mix. MLPA analyses were carried out on 24 of the 27 patients. The MLPA results from patient A corresponded, after normalization, to one copy number of the APC gene (Fig. 1, Table 1 ). As seen in Table 1 , a deletion of one copy of a probe target sequence was apparent by a reduction of about 50% in the relative peak area of the corresponding amplification product. Standard deviation of the control peak areas was below 10% for all probes. Patients B and C had normal copy numbers of all exons except exons 11, 12, and 13 (Fig. 1, Table 1 ).
FISH analysis on chromosome spreads from patient A was carried out for verification of the entire gene deletion. The result clearly shows the allele containing the wild-type APC gene on chromosome band 5q22 compared to the aberrant chromosome with the deletion (Fig. 2) .
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QRT-PCR
Gene dosage alterations of the APC gene was examined in 27 FAP patients with QRT-PCR. Figure 3 shows an example of a QRT-PCR measurement of APC exon 11 and ␤-globin and the derived standard curves. The relationship between crossing point and initial concentration was linear in the range of DNA concentrations used for all three APC fragments as well as the ␤-globin fragment. This was true independently of whether the different sets of primers and probes were multiplexed or not. In fact, the linearity extended from at least 0.1 ng to 100 ng (not shown), but because the analyzed DNA samples had similar concentrations, a narrower window was used in the assays. Agarose gel and melting curve analysis confirmed that the measured fluorescence originated from one single product of expected size.
The reliability of the assay was tested by using DNA samples of 8 healthy controls and by simulated deletion. The simulated deletion was made by comparing the amount of ␤-globin to the amount of APC fragment measured on a 1:1 dilution of the sample used for ␤-globin. The gene dosage ratios for the healthy controls varied between 0.99 and 1.05, with standard deviations of 0.03 to 0.08. The simulated deletion was tested on APC exon 3 and gave a ratio of 0.52 with the standard deviation of 0.04.
Of the 27 patients that were analyzed with QRT-PCR, 21 patients had ratios for the two APC exons within 10% from the theoretical value of 1. Three individuals were identified with deletion of one or more APC exons. Patient A showed a deletion including exon 3 and exon 11 with gene dosage ratios of 0.54 (stdd. 0.07) and 0.57 (std. 0.03), respectively. Patients B and C were found to be harboring deletions of exon 11 with ratios of 0.53 and 0.55, respectively ( Fig. 4B ; data not shown).
A common polymorphism, c.1458C Ͼ T, is located in the middle of the LightCycler (LC)-Red labeled probe for APC exon 11. Although hybridization probes are relatively tolerant to the presence of mismatches within the binding site, because the annealing and detection step is performed at a relatively low temperature compared to the melting temperature of the probe, we wanted to investigate if this had any consequence for the assay. No difference was seen in the measured ratios whether we used C or T homozygotes or C/T heterozygotes (not shown). In contrast, the presence of a polymorphism was used to further confirm the results in the case of heterozygotes, which gave two distinct peaks in the melting curve analysis (not shown).
To test the applicability of the method, relatives to patient B (for whom a deletion of exon 11 had been detected) were analyzed with QRT-PCR. The test included patient B and 3 healthy individuals as positive and negative controls as well as the mother, father, and brother of patient B. Previously performed haplotype analysis in conjunction with the clinical symptoms had identified the mother as affected and the father and brother as healthy (Fig. 4A) . The ratio of APC exon 11/␤-globin, as determined by QRT-PCR, was approximately 0.5 for patient B and the mother whereas a value of approximately 1 was found for the father, brother and the 3 healthy controls, thus confirming previous conclusions (Fig. 4B) .
Long-range PCR
To confirm the MLPA and QRT-PCR results of patients B and C, APC exons 11 through 13 were amplified on genomic DNA with long-range PCR. In addition to the expected 13-kb fragment present in healthy controls, both patients displayed an extra band of an estimated 8 kb, indicating a deletion of about 5 kb (data not shown). To find the actual deletion breakpoints, a series of internal primers and additional long-range amplifications were used to narrow down the deleted region. Direct sequencing on the purified PCR products revealed that the two apparently unrelated families had identical deletions, with the MEULLER ET AL. 252   FIG. 1 . Detection of deletions in the APC gene with MLPA. Probes were designed for each of the 15 APC exons (1-15S), and two additional for the promoter (P1-P2), one specific for the 5Ј untranslated region (5Ј), and two extra located in the middle and in the end of the large exon 15 (15M and 15 E; Table 1 ). An additional 11 control peaks (C) were designed, which are all specific for different genes on different chromosomes (Table 1 ). The 94-bp peak is a ligation-dependent synthetic control peak, specific for a 2q14 sequence. Arrows indicate presence of one exon copy only. (A) Capillary electrophoresis (CE) pattern from a control sample containing two copies of the APC gene. (B) CE pattern from patient A with a complete APC gene deletion including the promoter and 5Ј untranslated regions. (C) CE pattern from patient B with an APC exons 11-13 deletion.
5Ј breakpoint located 137 nucleotides upstream of exon 11 and the 3Ј-breakpoint 2,451 nucleotides downstream of exon 13, thus encompassing 4,453 nucleotides ( Fig. 5 ; APC IVS10-137_IVS13ϩ2451del4453bp).
DISCUSSION
The APC coding sequence consists of 8,535 bp spanning 15 exons in its most abundant isoform. Exon 15 comprises more than 75% of the coding sequence of the gene (Groden et al., 1991; Kinzler et al., 1991) . No aberrations were found in the APC gene of the investigated patients by previously performed standard mutation detection techniques. The majority of the methods routinely used to detect APC mutations are not genedose sensitive due to the presence of one normal allele. APCspecific MLPA and QRT-PCR methods were developed to detect alterations in gene dose.
Mutation detection FISH on metaphase spreads from patient A. The orange signal from the APC-specific probe is clearly visible on the normal chromosome 5, whereas no signal is detected on the aberrant chromosome 5. The green signal is generated from a 5p15.2-specific probe.
FIG. 3.
Real-time detection of PCR-amplified APC exon 11 (dotted line) and ␤-globin (solid line). The fluorescence signal (originating from the adjacent and simultaneous annealing of both probes in a hybridization probe pair to the double-stranded PCR product) was measured at the end of each annealing step and plotted against the number of executed PCR cycles. Each amplicon was measured at three different initial starting concentrations of human standard DNA (in the range from 0.48 ng to 12 ng per reaction). The decrease in fluorescence observed after the exponential phase for the ␤-globin amplicon is a probe-pair specific experimental artifact caused by competition between the hybridization probes and single-stranded PCR products. This so-called "hook effect" is only a "cosmetic" effect and the accuracy of the quantification is not affected by it because the fluorescence data needed for quanitification is gathered during the log-linear phase of the PCR. (Inset) A plot of crossing point, i.e., the fractional cycle number where the rate of change in fluorescence is fastest, versus the logarithm of initial template concentration from the PCR amplifications, shows a linear relationship for both APC exon 11 (dotted line) and ␤-globin (solid line) in the range of DNA concentrations used. This plot was also used as a standard curve for determining initial template concentration from the measured crossing points of unknown samples.
QRT-PCR and subsequently verified with FISH. Two families harboured a deletion covering exons 11-13. This aberration was initially detected as an exon 11 deletion by real-time PCR quantification in patients B and C. The two samples were analyzed by MLPA and the aberrant exon copy numbers produced were coinciding with the real-time PCR results. The deletion breakpoints were identified with long-range PCR and subsequent sequencing. The two apparently unrelated families of patients B and C were shown to carry the identical deletion APC IVS10-137_IVS13ϩ2451del4453bp. As a consequence of the deletion, the reading frame is changed, giving rise to a protein with changed amino acid sequence from position 470 and onwards until the premature stop at position 489. In family B two female obligate carriers were diagnosed with thyroid cancer. In a recent review (Truta et al., 2003) , the incidence of this cancer in FAP patients was estimated to 1-2% with a majority being female.
Repetitive elements and topoisomerase-mediated nonhomologous recombination have been proposed to be involved in genomic rearrangement in the APC gene (Cao et al., 2001) . To find out if the genomic region encompassing the deletion contained any known human repetitive sequences, we searched for repeats using the RepeatMasker program (http://ftp.genome. washington.edu). Several repetitive elements were found, but none coincided with the breakpoints. We also examined the sequence for the occurrence of topoisomerase recognition sites, because topoisomerase I and II have been suggested to mediate nonhomologous recombination (Konopka, 1988; Spitzner and Muller, 1988) . Several sites resembling topoisomerase I and II recognition sequences were identified (Fig. 5) . Furthermore, two kinds of symmetry around the breakpoints are highly noteworthy (Fig. 5) . The sequence TAGCT is present immediately upstream of each breakpoint and is preceded by the sequence TTTTTG (5Ј breakpoint) and AAAAAC (3Ј breakpoint). Whether the symmetry and/or the topoisomerase recognition sequences have any mechanistic significance is unclear.
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To provide high-quality and safe mutation detection screening of large, pathogenic deletions, the need for a method suitable for the clinical laboratory has been urgent. Allele drop out caused by this class of mutations may be a considerable cause of negative screening results in some disease-causing genes and populations. For clinical purposes, the European Molecular Genetics Quality network (http://www.emqn.org) guidelines suggests that at least two independent mutation detection techniques should be used to verify the presence of a germ-line mutation. MLPA and QRT-PCR use different detection and analysis formats. The use of different sets of primers, which eliminates the possibility of false negatives due to mismatches in the primer sequences and the use of different internal controls for normalization, emphasizes the complementarities of both approaches for the analysis of large genomic deletions.
In summary, our results show that MLPA and quantitative real-time PCR are rapid, reliable, and sensitive techniques suitable for the clinical laboratory and enabling precise and fast detection of gene copy numbers. MLPA may be used as one of the initiating methods for screening of disease genes, avoiding the risk of allele drop out in subsequent analyses due to deletions. As many diagnostic laboratories have collected hundreds of individuals/families with a predisposition to FAP, the APC-MLPA test makes it feasible to analyze all of these individuals and families for the presence of large genomic deletions.
